# Shanghai Pharma Group Changzhou Kony Pharmaceutical Co., Ltd. – FDA Inspection, Nov 10, 2023

Source: https://www.keypedia.com/records/fda_inspections/shanghai-pharma-group-changzhou-kony-pharmaceutical-co-ltd/b08a2f0e-abee-4aa8-90a7-10b89601c756
Source feed: FDA_Inspections

> FDA inspection 1223918 of Shanghai Pharma Group Changzhou Kony Pharmaceutical Co., Ltd., November 10, 2023. Classification: No Action Indicated (NAI). 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1223918
- Company Name: Shanghai Pharma Group Changzhou Kony Pharmaceutical Co., Ltd.
- Inspection Date: 2023-11-10
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 981948 - 2016-07-29

## Related Officers

- [Crystal Monroy](https://www.keypedia.com/people/crystal-monroy/b0414886-fb71-4f35-a453-0ad2baf13bfc)
- [Company Rep](https://www.keypedia.com/people/khoa-nathan-v-tran/678e5634-237c-4395-88a1-7418479e83c7)

Company: https://www.keypedia.com/companies/shanghai-pharma-group-changzhou-kony-pharmaceutical-co-ltd/7f636997-3af2-44e0-b1b8-bf487d8f6293

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c